Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment.
Philip M Hanno, Deborah Erickson, Robert Moldwin...
https://pubmed.ncbi.nlm.nih.gov/25623737Actively Recruiting
Led by The Third Affiliated hospital of Zhejiang Chinese Medical University · Updated on 2024-12-03
84
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are evaluating the efficacy and safety of acupuncture for treating bladder pain syndrome (BPS) in this randomized controlled trial with assessor blinding. The study compares electroacupuncture (EA) to medication with amitriptyline and a sham acupuncture group. It aims to improve symptoms such as pain, frequent urination, and emotional disorders while also exploring brain activity changes using fMRI. Participants are randomly assigned in a 1:2:1 ratio to one of three groups: medication with amitriptyline capsules taken twice daily for 4 weeks; EA treatment involving 12 sessions of acupuncture over 4 weeks with electrical stimulation at specified acupoints; or sham electroacupuncture with shallow needle insertion at non-acupoints without electrical stimulation, also for 12 sessions. Following treatment, there is a 4-week follow-up phase. Outcome assessors and statisticians are blinded, but acupuncturists and participants are aware of group assignments. Participants will be assessed at baseline, during treatment, and after follow-up using pain scales, questionnaires about urinary symptoms, 24-hour voiding diaries, and anxiety and depression scales. Brain activity will be monitored with fMRI to analyze changes in specific brain regions. The primary outcome is the change in pain intensity measured by the Visual Analog Scale at multiple timepoints. Safety and symptom changes will be closely monitored throughout the study, which lasts a total of 8 weeks for each participant.
CONDITIONS
EA for BPS: An RCT and Study for Central Mechanism
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 4 weeks
Participants receive either oral medication or acupuncture treatment sessions as part of the trial interventions.
3 visits per week for 4 weeks (total of 12 sessions) for acupuncture groups; daily medication intake for medication group
Duration - 4 weeks
Participants are assessed for outcomes including pain intensity, questionnaires, and scales after treatment ends.
Visits at week 4 and week 8 for outcome assessments
Total: 1 location
1
The Third Affiliated Hospital of Zhejiang Chinese Medical University
Hangzhou, Zhejiang, China, 310053
Actively Recruiting
Y
Yuanyuan Wu, PHD
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Philip M Hanno, Deborah Erickson, Robert Moldwin...
https://pubmed.ncbi.nlm.nih.gov/25623737Joop P van de Merwe, Jørgen Nordling, Pierre Bouchelouche...
https://pubmed.ncbi.nlm.nih.gov/17900797Philip M Hanno
https://pubmed.ncbi.nlm.nih.gov/18061027Katy S Konkle, Sandra H Berry, Marc N Elliott...
https://pubmed.ncbi.nlm.nih.gov/22177158J Curtis Nickel, Christopher K Payne, John Forrest...
https://pubmed.ncbi.nlm.nih.gov/19375108H Ouyang, J D Z Chen
https://pubmed.ncbi.nlm.nih.gov/15479354Amir Qaseem, Timothy J Wilt, Robert M McLean...
https://pubmed.ncbi.nlm.nih.gov/28192789Jessica Quinlan-Woodward, Autumn Gode, Jeffery A Dusek...
https://pubmed.ncbi.nlm.nih.gov/27768139Shiu-Lin Tsai, Lindsay M Fox, Mikiko Murakami...
https://pubmed.ncbi.nlm.nih.gov/27287548Yuan-Yuan Wu, Yong-Liang Jiang, Xiao-Fen He...
https://pubmed.ncbi.nlm.nih.gov/25821498